Dimopoulos, Meletios A; Cavo, Michele; Mateos, Maria-Victoria; Facon, Thierry; Heeg, Bart; van Beekhuizen, Sophie; Gebregergish, Samron B; Nair, Sandhya; Pisini, Marta; Lam, Annette; Slavcev, Mary, A matching-adjusted indirect treatment comparison (MAIC) of daratumumab-bortezomib-melphalan-prednisone (D-VMP) versus lenalidomide-dexamethasone continuous (Rd continuous), lenalidomide-dexamethasone 18 months (Rd 18), and melphalan-prednisone-thalidomide (MPT), «LEUKEMIA & LYMPHOMA», 2020, 61, pp. 714 - 720 [Scientific article]
Mattia D'Agostino, Juan-José Lahuerta, Ruth Wester, Anders Waage, Uta Bertsch, Elena Zamagni, Maria-Victoria Mateos, Alessandra Larocca, Daniele Dall'Olio, Niels W.C.J. Van De Donk, David Cairns, Serena Rocchi, Hans Salwender, Joan Blade Creixenti, Bronno van der Holt, Castellani Gastone, Giovannino Ciccone, Andrea Capra, Jan Dürig, Sara Bringhen, Sonja Zweegman, Michele Cavo, Hartmut Goldschmidt, Gordon Cook, Jesus Maria Hernández-Rivas, Jesus F. San-Miguel, Mario Boccadoro and Pieter Sonneveld, A new risk stratification model (R2-ISS) in Newly Diagnosed Multiple Myeloma: Analysis of Mature Data from 7077 patients collected by European Myeloma Network Within HARMONY Big Data Platform, in: 62nd ASH Annual Meeting & Exposition, 2020(atti di: 62nd ASH Annual Meeting & Exposition, All-virtual event, December 5-8,2020) [Poster]
Mattia D'agostino, Juan José Lahuerta, Anders Waage, Uta Bertsch, Elena Zamagni, Maria-Victoria Mateos, Alessandra Larocca, Daniele Dall'Olio, Niels WCJ van de Donk, Hans Salwender, Joan Bladé, Bronno van der Holt, Gastone Castellani, Giovannino Ciccone, Jan Dürig, Sara Bringhen, Sonja Zweegman, Michele Cavo, Hartmut Goldschmidt, Jesús María Hernandez Rivas, Jesus San Miguel, Mario Boccadoro, Pieter Sonneveld, A NEW RISK STRATIFICATION STRATEGY IN NEWLY DIAGNOSED MULTIPLE MYELOMA: AN ANALYSIS ON MATURE DATA FROM EUROPEAN CLINICAL TRIALS WITHIN THE HARMONY BIG DATA PLATFORM, in: Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020, «HEMASPHERE», 2020, 4, pp. 421 - 422 (atti di: 25th Congress of the European Hematology Association - 25th EHA Congress, Virtual edition, June 11-22, 2020) [Abstract]Open Access
Ocadlikova D.; Iannarone C.; Redavid A.R.; Cavo M.; Curti A., A screening of antineoplastic drugs for acute myeloid leukemia reveals contrasting immunogenic effects of etoposide and fludarabine, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 6802 , pp. 1 - 20 [Scientific article]Open Access
Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P., Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study, «THE LANCET. HAEMATOLOGY», 2020, 7, pp. e456 - e468 [Scientific article]
Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L., Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients, «HEMATOLOGICAL ONCOLOGY», 2020, 38, pp. 487 - 492 [Scientific article]
Mateos M.-V.; Fink L.; Koneswaran N.; Intorcia M.; Giannopoulou C.; Niepel D.; Cavo M., Bone complications in patients with multiple myeloma in five European countries: A retrospective patient chart review, «BMC CANCER», 2020, 20, Article number: 170 , pp. 1 - 13 [Scientific article]Open Access
Forte D.; Garcia-Fernandez M.; Sanchez-Aguilera A.; Stavropoulou V.; Fielding C.; Martin-Perez D.; Lopez J.A.; Costa A.S.H.; Tronci L.; Nikitopoulou E.; Barber M.; Gallipoli P.; Marando L.; Fernandez de Castillejo C.L.; Tzankov A.; Dietmann S.; Cavo M.; Catani L.; Curti A.; Vazquez J.; Frezza C.; Huntly B.J.; Schwaller J.; Mendez-Ferrer S., Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy, «CELL METABOLISM», 2020, 32, pp. 829 - 843 [Scientific article]Open Access
Tacchetti P.; Pantani L.; Patriarca F.; Petrucci M.T.; Zamagni E.; Dozza L.; Galli M.; Di Raimondo F.; Crippa C.; Boccadoro M.; Barbato S.; Tosi P.; Narni F.; Montefusco V.; Testoni N.; Spadano A.; Terragna C.; Pescosta N.; Marzocchi G.; Cellini C.; Galieni P.; Ronconi S.; Gobbi M.; Catalano L.; Lazzaro A.; De Sabbata G.; Cangialosi C.; Ciambelli F.; Musto P.; Elice F.; Cavo M.; Fanin R.; Foa' R.; Rambaldi A.; Rossi G.; Leoni P.; Corradini P.; Torelli G.; Fioritoni G.; Cortelazzo S.; Lambertenghi Deliliers G.; La Nasa G.; Zaccaria A.; De Fabritiis P.; Cascavilla N.; Bosi A.; Semenzato G.; Gugliotta L.; Gherlinzoni F.; Angelucci E.; Martelli M.F.; Petti M.C.; Leone G.; Carella A.M.; Ciceri F.; Santoro A.; Ferrara F.; Nobile F.; D'Arco A.M.; Levis A.; Guardigni L.; Gallamini A.; Fattori P.P.; Morandi S.; Amadori D.; Rotoli B.; Mirto S.; Paladini G.; Mozzana R.; Pinotti G.; Rodeghiero F.; Cantore N.; Pavone V.; Pogliani E.M.; Liberati A.M.; Majolino I.; Amadori S.; Lauria F.; Aglietta M., Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study, «THE LANCET. HAEMATOLOGY», 2020, 7, pp. 861 - 873 [Scientific article]
Coppola, Paolo E.; Gaibani, Paolo; Sartor, Chiara; Ambretti, Simone; Lewis, Russell E.; Sassi, Claudia; Pignatti, Marco; Paolini, Stefania; Curti, Antonio; Castagnetti, Fausto; Ursi, Margherita; Cavo, Michele; Stanzani, Marta, Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients, «MICROORGANISMS», 2020, 8, pp. 1 - 11 [Scientific article]Open Access
Lolli G.; Broccoli A.; Stefoni V.; Argnani L.; Leone O.; Cavo M.; Zinzani P.L., Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental finding, «TUMORI», 2020, 106, pp. 29 - 32 [Scientific article]
Passamonti, Francesco; Cattaneo, Chiara; Arcaini, Luca; Bruna, Riccardo; Cavo, Michele; Merli, Francesco; Angelucci, Emanuele; Krampera, Mauro; Cairoli, Roberto; Della Porta, Matteo Giovanni; Fracchiolla, Nicola; Ladetto, Marco; Gambacorti Passerini, Carlo; Salvini, Marco; Marchetti, Monia; Lemoli, Roberto; Molteni, Alfredo; Busca, Alessandro; Cuneo, Antonio; Romano, Alessandra; Giuliani, Nicola; Galimberti, Sara; Corso, Alessandro; Morotti, Alessandro; Falini, Brunangelo; Billio, Atto; Gherlinzoni, Filippo; Visani, Giuseppe; Tisi, Maria Chiara; Tafuri, Agostino; Tosi, Patrizia; Lanza, Francesco; Massaia, Massimo; Turrini, Mauro; Ferrara, Felicetto; Gurrieri, Carmela; Vallisa, Daniele; Martelli, Maurizio; Derenzini, Enrico; Guarini, Attilio; Conconi, Annarita; Cuccaro, Annarosa; Cudillo, Laura; Russo, Domenico; Ciambelli, Fabrizio; Scattolin, Anna Maria; Luppi, Mario; Selleri, Carmine; Ortu La Barbera, Elettra; Ferrandina, Celestino; Di Renzo, Nicola; Olivieri, Attilio; Bocchia, Monic, Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study, «THE LANCET. HAEMATOLOGY», 2020, 7, pp. 737 - 745 [Scientific article]
Di Bacco A.; Bahlis N.J.; Munshi N.C.; Avet-Loiseau H.; Masszi T.; Viterbo L.; Pour L.; Ganly P.; Cavo M.; Langer C.; Kumar S.K.; Rajkumar S.V.; Keats J.J.; Berg D.; Lin J.; Li B.; Badola S.; Shen L.; Zhang J.; Esseltine D.-L.; Luptakova K.; van de Velde H.; Richardson P.G.; Moreau P., c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2020, 105, pp. 35 - 46 [Scientific article]Open Access
Cavo M.; Dimopoulos M.A.; San-Miguel J.; Mateos M.-V.; Jakubowiak A.; Deraedt W.; Lam A.; Kampfenkel T.; Qi M.; He J., Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2020, 20, pp. 480 - 489 [Scientific article]
Parasrampuria D.A.; He J.; Zhang L.; Muresan B.; Hu P.; Nemat S.; Hashim M.; Lam A.; Appiani C.; Cavo M.; Dimopoulos M.A.; San-Miguel J.; Mateos M.-V., Comparison of efficacy from two different dosing regimens of bortezomib: an exposure–response analysis, «BRITISH JOURNAL OF HAEMATOLOGY», 2020, 189, pp. 860 - 868 [Scientific article]
